Maine Behavioral Healthcare
-
Services:
- Mental health treatment
- Haloperidol
- Aripiprazole
- Loxapine
- Chlorpromazine
- Perphenazine
- Ziprasidone
- Non-nicotine smoking/tobacco cessation
- Risperidone
- Olanzapine
- Antipsychotics used in treatment of SMI
- Olanzapine/Fluoxetine combination
- Clozapine
- Paliperidone
- Nicotine replacement
- Fluphenazine
- Quetiapine
- Activity therapy
- Cognitive behavioral therapy
- Smoking/vaping/tobacco cessation counseling
- Vaping permitted in designated area
- Adults
- Young Adults
- Seniors
- Residential/24-hour residential
- Persons experiencing first-episode psychosis
- Lesbian, gay, bisexual, transgender, or queer/questioning (LGBTQ)
- Persons 18 and older with serious mental illness (SMI)
- Clients with co-occurring mental and substance use disorders
- Psychiatric emergency mobile/off-site services
- Private non-profit organization
- Residential treatment center (RTC) for adults
- Smoking permitted in designated area
- Screening for tobacco use
- County or local government funds
- Medicaid
- Medicare
- Psychosocial rehabilitation services
- Diet and exercise counseling
- Suicide prevention services
- Supported employment
- Case management service
- Housing services
- Mentoring/peer support
Type of Care
Pharmacotherapies
Treatment Approaches
Education and Counseling Services
Facility Vaping Policy
Age Groups Accepted
Service Setting (e.g., Outpatient, Residential, Inpatient, etc.)
Special Programs/Groups Offered
Emergency Mental Health Services
Facility Operation (e.g., Private, Public)
Facility Type
Facility Smoking Policy
Assessment/Pre-treatment
Payment/Insurance/Funding Accepted
Ancillary Services
Recovery Support Services